Indraprastha Medical Corporation Limited

NSEI:INDRAMEDCO Stock Report

Market Cap: ₹24.6b

Indraprastha Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Shivakumar Pattabhiraman

Chief executive officer

₹24.3m

Total compensation

CEO salary percentage96.6%
CEO tenure4.5yrs
CEO ownershipn/a
Management average tenure4.5yrs
Board average tenure4.7yrs

Recent management updates

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15
We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Recent updates

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Apr 06
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Feb 01
Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Nov 03
Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15
We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Sep 10
Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 27
Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Aug 08
Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Jul 31
Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

Jan 21
Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Nov 12
We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Nov 02
Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

May 12
Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Jun 10
Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

Feb 21
Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

CEO Compensation Analysis

How has Shivakumar Pattabhiraman's remuneration changed compared to Indraprastha Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹964m

Mar 31 2023₹24m₹23m

₹862m

Dec 31 2022n/an/a

₹815m

Sep 30 2022n/an/a

₹765m

Jun 30 2022n/an/a

₹635m

Mar 31 2022₹26m₹26m

₹586m

Dec 31 2021n/an/a

₹585m

Sep 30 2021n/an/a

₹546m

Jun 30 2021n/an/a

₹430m

Mar 31 2021₹12m₹11m

₹23m

Dec 31 2020n/an/a

-₹63m

Sep 30 2020n/an/a

-₹76m

Jun 30 2020n/an/a

₹99m

Mar 31 2020₹25m₹10m

₹436m

Compensation vs Market: Shivakumar's total compensation ($USD291.24K) is above average for companies of similar size in the Indian market ($USD185.46K).

Compensation vs Earnings: Shivakumar's compensation has been consistent with company performance over the past year.

CEO

Shivakumar Pattabhiraman (57 yo)

4.5yrs

Tenure

₹24,279,746

Compensation

Mr. Shivakumar Pattabhiraman, B Com ACA Grad., CWA, serves as Managing Director and Additional Director of Indraprastha Medical Corporation Limited since November 5, 2019. He served as a Chief Financial an...

Leadership Team

NamePositionTenureCompensationOwnership
Shivakumar Pattabhiraman
MD & Additional Director4.5yrs₹24.28mno data
Chander Tyagi
Chief Financial Officer5.9yrs₹12.30mno data
Priya Ranjan
Company Secretary & Compliance Officer3.8yrs₹8.20mno data

4.5yrs

Average Tenure

Experienced Management: INDRAMEDCO's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Shivakumar Pattabhiraman
MD & Additional Director4.5yrs₹24.28mno data
Vineeta Rai
Independent Non-Executive Director9.5yrs₹1.53m0%
₹ 0
Vinayak Chatterjee
Independent Non-Executive Director8.1yrs₹1.30mno data
Prathap Reddy
Non-Executive Vice Chairmanno data₹975.00k0.26%
₹ 63.5m
Madhumita Ganguli
Independent Director4.8yrs₹900.00kno data
Sangita Reddy
Non-Executive Director3.8yrs₹1.28m0.011%
₹ 2.7m
Suneeta Reddy
Non-Executive Director18.8yrs₹1.38m0.15%
₹ 37.0m
Salil Singhal
Independent Non-Executive Director3.3yrs₹1.03mno data
Mahesh Verma
Non-Executive Director3.3yrs₹1.25mno data
Arun Rai
Independent Director9yrs₹1.28mno data
Menaka Guruswamy
Independent Non-Executive Woman Director4yrs₹1.10mno data

4.7yrs

Average Tenure

64yo

Average Age

Experienced Board: INDRAMEDCO's board of directors are considered experienced (4.7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.